Literature DB >> 7594231

About the effects of glucagon on growth hormone release.

A E Pontiroli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594231     DOI: 10.1007/BF03347845

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  7 in total

1.  Growth hormone response to arginine in normal subjects and in patients with chemical diabetes and effect of clofibrate and of metergoline.

Authors:  A E Pontiroli; G Viberti; G Pozza
Journal:  Proc Soc Exp Biol Med       Date:  1977-06

2.  Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients.

Authors:  A E Pontiroli; A Calderara; E Pajetta; M Alberetto; G Pozza
Journal:  Diabetes Care       Date:  1989-10       Impact factor: 19.112

3.  Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects.

Authors:  A E Pontiroli; R Lanzi; L D Monti; G Pozza
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

4.  Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.

Authors:  A E Pontiroli; M G Perfetti; A C Andreotti; B Fattor; L D Monti; G Pozza
Journal:  Metabolism       Date:  1993-10       Impact factor: 8.694

5.  Pharmacokinetics of intranasal, intramuscular and intravenous glucagon in healthy subjects and diabetic patients.

Authors:  A E Pontiroli; A Calderara; M G Perfetti; S R Bareggi
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses.

Authors:  R H Rao; G S Spathis
Journal:  Metabolism       Date:  1987-07       Impact factor: 8.694

7.  Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity.

Authors:  E Ghigo; E Bartolotta; E Imperiale; J Bellone; G Cardinale; G Aimaretti; M R Valetto; V Cherubini; M Maccario; D Cocchi
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

  7 in total
  2 in total

1.  Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects.

Authors:  E Arvat; B Maccagno; J Ramunni; R Giordano; L DiVito; F Broglio; M Maccario; F Camanni; E Ghigo
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

2.  Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity.

Authors:  F Tassone; S Grottoli; R Rossetto; B Maccagno; C Gauna; R Giordano; E Ghigo; M Maccario
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.